MedTrace Logo

Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric Cancer

NCT02240524 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 582

Last updated 2014-09-15

No results posted yet for this study

Summary

The purpose of this study is to study the efficacy of hyperthermic intraperitoneal chemotherapy in the treatment of patients with locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy. It is a multicentric and randomised phase III trial.

Conditions

  • Advanced Gastric Adenocarcinoma

Interventions

PROCEDURE

D2 lymphadenectomy

The dissected lymph nodes were classified according to the Japanese Classification of Gastric Carcinoma, first English edition.

PROCEDURE

Systemic chemotherapy

PROCEDURE

HIPEC

Sponsors & Collaborators

  • Affiliated Cancer Hospital & Institute of Guangzhou Medical University

    lead OTHER

Principal Investigators

  • shuzhong cui, Ph.D · Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02240524 on ClinicalTrials.gov